
Ardelyx fell 46.5% from $5.83 to $3.12, behind the S&P 500's +12.3%. Its worst day was Aug 7 (−17.9%), and its low came Nov 6 at $2.88.
Nov 13, 2025 – Nov 12, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Company achieved significant commercial progress in 2025, generating approximately $378 million in product revenue1 IBSRELA achieved $274 million in revenue in 2025, representing 73% growth vs.
+20.1%, the year's best day · S&P 500 0.0%
Story events cover the past 12 months · Times ET
Ardelyx closed at its highest level of the year, 37.0% above where the year started.
+3.0% · S&P 500 +1.2%
EPS of $0.00 missed the $0.01 estimate on $125.2M revenue (est. $117.9M).
−15.0% · S&P 500 +0.7%
EPS of $-0.15 missed the $-0.14 estimate on $94.5M revenue (est. $92.4M).
+8.7% · S&P 500 +0.3%
EPS of $-0.07 missed the $-0.04 estimate on $118.1M revenue (est. $127.1M).
−17.9%, the year's worst day, on 20M shares, the year's heaviest volume · S&P 500 +0.6%
EPS of $0.00 beat the $-0.02 estimate on $125.5M revenue (est. $127.3M).
+8.6% · S&P 500 +1.7%
Where it ended: a close of $3.12 on Nov 12, 2026. Up next: Q4 2026 earnings on Feb 18, 2027 (EPS est. $0.03, revenue est. $139.8M).
Nothing in the past 12 months.
All ARDX dividend historyReplay the year: the line draws itself and stops at each of the 6 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for ARDX and SPY from Benzinga historical bars. Not investment advice.